Navigation path

News Highlights

10 October 2017

Evaluation of the Innovative Medicines Initiative now published

The reports on the evaluation of the seven public-private partnerships, the so-called Joint Undertakings (JUs) under Horizon 2020, and their six predecessors under the previous seventh framework programme, have been published. This includes a Staff Working Document presenting the Commission services' view on the performance of the seven JUs under Horizon 2020. The experts concluded that the Innovative Medicines Initiative “remains both relevant and justified” under Horizon 2020 and that “positive contributions on the drug development process are expected, but results are yet to be realised as the first projects under IMI2 JU only started in 2014”.

More information


9 October 2017

EU–funded project aims at developing an effective Tuberculosis vaccine

Supported by Horizon 2020 with EUR 18.2m, TBVAC2020 research project aims at the discovery and development of novel tuberculosis (TB) vaccines from preclinical research projects to early clinical assessment. Over 50% of the global pipeline in TB vaccine candidates currently evaluated in clinical trials originate from EU–funded projects. The European Commission has played a key leadership role in accelerating TB vaccine research and development and ensured a well-coordinated and efficient TB vaccine research consortium.

More information


5 October 2017

Registration open! Health, demographic change and wellbeing Info Day

8 December 2017, Brussels

With the principle of better health for all at its core, Horizon 2020's Societal Challenge 1 (Health, demographic change and wellbeing) will be presented during the Health Information Day on 8 December 2017 in Brussels. Societal Challenge 1 (expected budget approx.. EUR 2 billion) focuses on personalised health and care, infectious diseases and improving global health, innovative and sustainable health systems, decoding the role of the environment (including climate change) for health and wellbeing, digital transformation and cybersecurity in health and care.

Related to the Health Open Info Day, the Directorate-General for Research & Innovation supports two events organised on 7 December 2017 (Brussels): Innovation Procurement in health care and the Partnering Event coordinated by the EU–funded project Health-NCP-Net 2.0.

More information


29 September 2017

Directorate-General Research & Innovation at the European Health Forum Gastein

DG Research & Innovation invites you to take part in the two interactive sessions organised at the European Health Forum Gastein:

  • 4 October, 9:00-11:00, Personalising healthcare: How rare diseases pave the way
  • 5 October, 16:00-18:30, Environment & health: Building the evidence base for policy

More information


28 September 2017

EU-funded project ALIVER produces new dialysis technology

EU-funded project ALIVER has developed and optimised a novel liver dialysis device called DIALIVE. By 2020 a new dialysis technology could be available and extend the lives of people with cirrhosis long enough for their liver to start recovering or to find a donor for a liver transplant.

More information


22 September 2017

EC and EIB grant EUR 20m loan to speed up solutions for the prevention and treatment of antibiotic–resistant infections

This key loan is designed to finance Da Volterra, a French biopharmaceutical company, toward the development in the area of prevention and treatment of antibiotic-resistant serious infectious and hospital-acquired diseases. This financial support is being provided under Horizon 2020, the current EU framework programme for research and innovation., and more particularly the InnovFin Infectious Diseases Finance Facility, which offers bespoke products for financing high-risk projects in the field of infectious diseases.

More information


13 September 2017

Personalised medicine days in Toulouse and London

EU–funded project U-PGx aims to address major challenges and obstacles for the implementation of pharmacogenomics testing in patient care, taking into account the diversity of healthcare systems and citizens across Europe. As part of the dissemination and outreaching activities the project will organise the personalised medicine days:

More News Headlines

 

 

Success Stories

Cell-free heart valve offers promise of normal life

Image of hand with a red heartEU-funded researchers have developed and tested a way to make human heart valve implants more tolerable and longer lasting, enabling recipients of all ages to avoid follow-up surgery and live largely normal lives, cutting hospital stays and healthcare costs.

Read more Success Stories

Social Corner

twitter logo

Follow us on Twitter


Facebook logo Find us on Facebook on the EU Science & Innovation page page